首页> 中国专利> 治疗颈腰椎病用途的药物

治疗颈腰椎病用途的药物

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明涉及苯溴香豆素或其药学上可接受的不同的结晶，或其药学上可接受的溶剂合物，或药学上可接受的盐或其药学上可接受的酯或醚或其药学上可接受的包合物，或含有它们中任何一种的药用组合物在制造药物中的用途，该药物用于制备治疗和预防人的颈椎病或腰椎间盘突出病的药物中的应用。

著录项

公开/公告号CN104666292B

专利类型发明专利
公开/公告日2020-02-18

原文格式PDF
申请/专利权人刘力;
展开▼

申请/专利号CN201410709654.1
发明设计人刘力;胡梨芳;
展开▼

申请日2014-11-28
分类号
代理机构北京华沛德权律师事务所;
代理人刘杰
地址 528500 广东省佛山市高明区荷城区松涛街3号2座2梯302室
入库时间 2022-08-23 10:51:04

法律信息

法律状态公告日

法律状态信息

法律状态
2020-02-18

授权

授权
2015-07-01

实质审查的生效 IPC(主分类):A61K31/343 申请日:20141128

实质审查的生效
2015-07-01

实质审查的生效 IPC(主分类):A61K 31/343 申请日:20141128

实质审查的生效
2015-06-03

公开

公开
2015-06-03

公开

公开

相似文献

专利
中文文献
外文文献

1. 治疗颈腰椎病用途的药物 [P] . 中国专利： CN104666292B . 2020.02.18
2. 治疗颈腰椎病变及风湿类风湿病的药物及其制备方法 [P] . 中国专利： CN110123932A . 2019-08-16
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. compound, pharmaceutical composition, use of a compound for the preparation of a medicament for the treatment of a condition resulting from an abnormality of nitric oxide production, use of a compound for the preparation of a medicament for the treatment of pain in an individual with need thereof and use of a compound for the preparation of a medicament for the treatment of inhibition of dimerization of inos [P] . BRPI0518096A . 2008-10-28

机译：化合物，药物组合物，该化合物在制备用于治疗由一氧化氮产生异常导致的病症的药物中的用途，该化合物在制备用于治疗有需要的个体中的疼痛的药物中的用途化合物及其在制备药物中的用途，所述药物用于抑制肌苷二聚化
5. Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals [P] . BR0102185A . 2003-02-18

机译：包含catuama提取物作为抗氧化剂或脑血管舒张剂的产品的用途，包含该产品的药物组合物用于预防或治疗由自由基的不当存在引起的血管疾病和病症，预防或治疗脑血管疾病和病症的方法由于使用所述产品不当按压自由基而导致的疾病，以及所述产品在制备药物组合物中的用途，所述药物组合物用于预防或治疗血管疾病和由自由基的不当存在引起的疾病